RhumbLine Advisers’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $532K | Buy |
|
|||||
|
2025
Q2 | $505K | Sell |
|
|||||
|
2025
Q1 | $518K | Buy |
|
|||||
|
2024
Q4 | $766K | Buy |
|
|||||
|
2024
Q3 | $702K | Sell |
|
|||||
|
2024
Q2 | $598K | Buy |
|
|||||
|
2024
Q1 | $1.44M | Buy |
|
|||||
|
2023
Q4 | $3.76M | Buy |
|
|||||
|
2023
Q3 | $3.2M | Buy |
|
|||||
|
2023
Q2 | $5.08M | Sell |
|
|||||
|
2023
Q1 | $4.67M | Buy |
|
|||||
|
2022
Q4 | $2.94M | Buy |
|
|||||
|
2022
Q3 | $2.05M | Buy |
|
|||||
|
2022
Q2 | $1.46M | Buy |
|
|||||
|
2022
Q1 | $2.15M | Sell |
|
|||||
|
2021
Q4 | $5.01M | Sell |
|
|||||
|
2021
Q3 | $6.34M | Sell |
|
|||||
|
2021
Q2 | $8.73M | Buy |
|
|||||
|
2021
Q1 | $7.18M | Sell |
|
|||||
|
2020
Q4 | $5.81M | Buy |
|
|||||
|
2020
Q3 | $1.94M | Sell |
|
|||||
|
2020
Q2 | $730K | Buy |
|
|||||
|
2020
Q1 | $595K | Sell |
|
|||||
|
2019
Q4 | $1.04M | Buy |
|
|||||
|
2019
Q3 | $1.02M | Buy |
|
|||||
|
2019
Q2 | $1.19M | Buy |
|
|||||
|
2019
Q1 | $1.3M | Buy |
|
|||||
|
2018
Q4 | $1.29M | Buy |
|
|||||
|
2018
Q3 | $596K | Sell |
|
|||||
|
2018
Q2 | $415K | Buy |
|
|||||
|
2018
Q1 | $205K | Sell |
|
|||||
|
2017
Q4 | $267K | Sell |
|
|||||
|
2017
Q3 | $570K | Buy |
|
|||||
|
2017
Q2 | $372K | Buy |
|
|||||
|
2017
Q1 | $527K | Buy |
|
|||||
|
2016
Q4 | $377K | Buy |
|
|||||
|
2016
Q3 | $830K | Buy |
|
|||||
|
2016
Q2 | $625K | Buy |
|
|||||
|
2016
Q1 | $655K | Buy |
|
|||||
|
2015
Q4 | $956K | Buy |
|
|||||
|
2015
Q3 | $240K | Sell |
|
|||||
|
2015
Q2 | $449K | Buy |
|
|||||
|
2015
Q1 | $450K | Buy |
|
|||||
|
2014
Q4 | $518K | Buy |
|
|||||
|
2014
Q3 | $268K | Sell |
|
|||||
|
2014
Q2 | $345K | Sell |
|
|||||
|
2014
Q1 | $366K | Sell |
|
|||||
|
2013
Q4 | $361K | Sell |
|
|||||
|
2013
Q3 | $395K | Sell |
|
|||||
|
2013
Q2 | $181K | Buy |
|